Journals / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 3

Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets

Pages
218–223
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our findings suggest that N/L ratio is an inexpensive, universally available hematological marker for sufficiency of CCC in patients with stable coronary artery disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The heterogeneity in the degree of collateralization among patients with coronary artery disease (CAD) remains incompletely under- stood.
📊
Key Findings & Data:Methods: Current study is a retrospective study, consisting of 118 patients with poor CCC and 130 patients with good CCC.
💡
Conclusion & Impact:Our findings suggest that N/L ratio is an inexpensive, universally available hematological marker for sufficiency of CCC in patients with stable coronary artery disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The heterogeneity in the degree of collateralization among patients with coronary artery disease (CAD) remains incompletely under- stood. We evaluated the predictors of poorly developed coronary collateral circulation (CCC) in patients with stable coronary artery disease. Methods: Current study is a retrospective study, consisting of 118 patients with poor CCC and 130 patients with good CCC. We investigated predictors of poor coronary collaterals in a cohort of 248 patients who had high-grade coronary stenosis or occlusion on their angiograms. To classify CCC, we used the Rentrop classification. Results: Patients with poorly developed CCC had significantly higher neutrophil-to-lymphocyte ratio (N/L) compared with those with well- developed CCC, (4.2±2.8 vs. 3±3.1, p=0.001), whereas mean platelet volume, red cell distribution width and uric acid were not significantly dif- ferent. Logistic regression analysis showed that N/L ratio (odds ratio 1.199, 95% confidence interval 1.045-1.375) and serum triglyceride levels [odds ratio (OR)=1.006, 95% confidence interval (CI)=1.001-1.010] were independent predictors of poorly developed CCC. Conclusion: An elevated level of N/L ratio is independently associated with a significant impairment in coronary collateralization. Our findings suggest that N/L ratio is an inexpensive, universally available hematological marker for sufficiency of CCC in patients with stable coronary artery disease.

🔖

Cite This Article

AKIN, F., AYÇA, B., ÇELİK, Ö., ŞAHİN, C. (2015). Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 3, 218–223. https://ajindex.com/articles/365932

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collat- eral circulation during sudden controlled coronary artery occlu- sion in human subjects: a prospective study. Circulation 1986
  2. [CrossRef] 2. Williams DO, Amsterdam EA, Miller RR, Mason DT. Functional sig- nificance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. Am J Cardiol 1976
  3. [CrossRef] 3. Billinger M, Kloos P, Eberli FR, Windecker S, Meier B, Seiler C. Physiologically assessed coronary collateral flow and adverse car- diac ischemic events: a follow-up study in 403 patients with coro- nary artery disease. J Am Coll Cardiol 2002
  4. [CrossRef] 4. Abacı A, Oğuzhan A, Kahraman S, Eryol NK, Ünal S, Arınç H, et al. Effect of diabetes mellitus on formation of coronary collateral ves- sels. Circulation 1999
  5. [CrossRef] 5. Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abacı A, Çengel A. Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis 2008
  6. [CrossRef] 6. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999
  7. [CrossRef] 7. Mitsuma W, Kodama M, Hirono S, Ito M, Ramadan MM, Tanaka K, et al. Angiopoietin-1, angiopoietin-2 and tie-2 in the coronary circu- lation of patients with and without coronary collateral vessels. Circ J 2007
  8. [CrossRef] 8. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005
  9. [CrossRef] 9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007
  10. [CrossRef] 10. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care 2011
  11. e61-e99. [CrossRef] 11. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/ Canadian guidelines for the diagnosis and treatment of dyslipid- emia